Biomarker (or Genomic Diagnostic) testing is key in today’s world of precision medicine. Lung cancer biomarker testing is also known as tumor testing, genetic mutation testing, next generation sequencing (NGS) or genomic testing. It looks for changes in the
...
Senior Year Disrupted In a Flash In May, 2014, Corey Wood was your typical 22-year old college student. A senior at Cal Berkeley, she was juggling classes, a job, and an internship, all in preparation to graduate and begin
...
ALK positive (anaplastic lymphoma kinase positive, or ALK+) lung cancer occurs in 1 out of 25 non-small-cell lung cancer patients (NSCLC — the most common type of lung cancer). Younger patients — usually 55 and under — who have
...